American Head & Neck Society

Advancing Education, Research, and Quality of Care for the Head and Neck oncology patient.

  • About
    • Mission Statement and Purpose
    • Divisions & Services of the Society
      • Education
        • Scientific Program/Resident Courses
        • Surgical Videos
        • Journal Club
        • Journals
        • Global Outreach
        • Awards
          • Margaret F. Butler Award
      • Diversity, Equity and Inclusion Division
      • Patient Care
        • Cancer Survivorship
          • Patient Education on Post-Treatment Care
          • Interviews with Cancer Survivors
        • Cancer Prevention
          • SLIDE DECK: HPV-Related Oropharyngeal Cancer
        • Guidelines/Position Statements
        • Find-A-Physician
      • Research
        • Grant Information
        • Clinical Trial
        • Tissue Banks
      • Administrative Division
        • AHNS Process for Evaluating Projects Requiring Funding
    • Leadership
    • History
      • Society Background
      • AHNS History Interviews
      • Past Presidents
      • In Memory
    • AHNS Newsletter
    • Professionalism & Ethics
    • AHNS Policies and Procedures (P&P) Manual
    • AHNS Foundation
    • AHNS Bylaws
    • AHNS Staff
    • AHNS News and Announcements
    • COVID-19 Bulletin Board
  • Heads Up!
  • Post a Job
  • Meetings
    • AHNS Virtual Education Series
      • TORS Webinar Series
    • AHNS Meetings Info
    • AHNS Call For Abstracts
    • Past Meetings
    • Related Meetings
  • For Patients
  • For Trainees
    • Fellowship Curriculum for FY2024-2025
      • For Current AHNS Fellows
      • Certificate of Completion Request
    • Accredited Fellowships
      • Directory of Fellowships
      • AHNS Fellowship Match
      • Fellowship Curriculum
      • Fellowship Graduates
      • For Program Directors
    • AHNS Surgical Videos
    • Fellows’ Virtual Tumor Boards
    • Cutaneous Cancer
  • Sections
    • Endocrine Surgery
    • Skull Base Surgery Section
    • Reconstructive Head & Neck Surgery
      • Head and Neck Reconstruction- Information for Patients
    • Mucosal Malignancy Section
      • Mucosal Malignancy Section Patient Information
    • Salivary Gland Section
      • Salivary Gland Section Patient Education Handout: Parotidectomy
    • Cutaneous Cancer
  • Find-A-Physician
  • Member Central
    • Join AHNS
    • Find-A-Physician
    • Mailing List Order
  • Login
    • Password Reset
  • Donate

2008 Conference: PowerPoint Presentations

[tabs][tab title=”Saturday“]

Instructional Courses

  • HNSCC Cases for AHNS – 3 Cases Presentation
  • SIERRA B: Systemic Therapy in SCCHN
  • SIERRA B: The Role of Systemic Therapy in Locally Advanced Squamous Cell Carcinoma of the Head & Neck
  • SIERRA B: Quality of Head & Neck Cancer Care: How Do We Improve?
  • SIERRA H: Electronic Medical Record Systems in a Head & Neck Oncologic Practice
  • SIERRA H: Screening and Early Diagnosis of Oral Cancer
  • SIERRA H: What’s New in Padiotherapy for Head & Neck Cncer?
  • SIERRA I: IRB/GRANTS – Institutional Review Board 101
  • SIERRA I: Decision making in the Management of the Mandible in Oral Cancer
  • SIERRA I: Nuts and Bolts of Tissue Banking
  • SIERRA I: Quality of Life, Symptom Control and Functional Outcomes
  • SIERRA I: Tumor Board: Oral Cavity “The Role of Sentinel Node Biopsy”
  • SIERRA I: IRB/GRANTS – Get Your Grant Funded
  • SIERRA I: The Abstrusity of QOL
  • NOB HILL A: Multidisciplinary Head & Neck Cancer Care in the Community
  • NOB HILL A: Surgical Options for Distant Metastases
  • NOB HILL A: Multidisciplinary Management of Head & Neck Cancer Care in the Community Setting
  • YERBA SALON 10-11: Linear Stapler in Total Laryngectomy
  • YERBA SALON 10-11: Mini-course on Surgical Technique for Larynx
  • YERBA SALON 10-11: Introduction to Oncogenomics/Proteomics 101
  • YERBA SALON 10-11: Post Operative Radiotherapy for Head & Neck Tumors
  • YERBA SALON 10-11: Minimally Invasive Thyroid. Videoassisted Thyroidectomy
  • YERBA SALON 10-11: Videoassisted Thyroidectomy: Lessons After 2 Years
  • YERBA SALON 10-11: Robotics Neck Surgery: a Systematic Approach to Implementing a New Surgical Technique
  • YERBA SALON 10-11: Adjuvant Radiation and Chemotherapy in the Treatment of Squamous Cell Carcinoma of the Head & Neck
  • YERBA SALON 10-11: Transoral Robotic Surgery (TORS) Program – From the Bench to the Bedside
  • YERBA SALON 12-13: Surgical Technique on Salivary Glands
  • YERBA SALON 12-13: Speech and Swallowing Rehabilitation
  • YERBA SALON 12-13: Surgical Eintervention for Dysphagia and Aspiration
  • YERBA SALON 12-13: Damage Control
  • YERBA SALON 12-13: Instructional Session: Salivary Gland Surgery
  • YERBA SALON 12-13: Sonographic Evaluation of Lymph Nodes with Head & Neck Cancer
  • YERBA SALON 14: The Search for Cancer Stem Cell in Head & Neck Squamous Cell Carcinoma
  • YERBA SALON 14: Combined Therapy for Squamous Cancer of the Oropharyrnx
  • YERBA SALON 14: Combined Therapy for Oropharyrnx Cancer
  • YERBA SALON 14: Target Therapy 101
  • YERBA SALON 15: National Reimbursement Scene for Physicians
  • YERBA SALON 15: Stereolithographic Modeling for Mandibular Reconstruction
  • YERBA SALON 15: Reimbursement in Head &Neck Oncologic Surgery
  • YERBA SALON 15: Management of the Neck in the Treatment of Oropharyngeal Cancer
  • YERBA SALON 15: Radiotherapy for Hypopharynx Cancer
  • YERBA SALON 15: Cancer of the Hypopharynx
[/tab][tab title=”Sunday“]
  • YERBA SALON 1-2: Tumor Volume as Outcome Predictor in Chemoradiation for Advanced Head & Neck Cancer
  • YERBA SALON 1-2: CI-1040 Inhibits Growth of Papillary Thyroid Carcinoma
  • YERBA SALON 1-2: IRX-2, a Multi-targeted Biologic, Protects T Cells from Tumor-induced Cell Death
  • YERBA SALON 1-2: Does Post-treatment Surveillance Improve survival in Head & Neck cancer Patients?
  • YERBA SALON 1-2: HPV-16 Influence on Oropharyngeal Cancer Treated in a Large Multidisciplinary Setting
  • YERBA SALON 1-2: Involvement of Rho C in Head & Neck Cancer Metastasis
  • YERBA SALON 1-2: Levels of CD44, a Head & Neck Cancer Stem Cell Marker, Correlate with Tumor Aggressiveness
  • YERBA SALON 1-2: Cetuximab Mediated Lysis is regulated by Polymorphic FcγR-IIIa NK Cells
  • YERBA SALON 1-2: DAHANCA 10 – a Randomized Study of Aranesp® as Modifier of Radiotherapy in Patients with Primary HNSCC
  • YERBA SALON 1-2: HPV-16 E6 and E7 Transactivate a Human Endogenous Retroviral Superantigen that is Expressed in HPV+OSCC
  • YERBA SALON 1-2: Phase II Study of Bevacizumab, Docetaxel and Radiation in Locally Advanced Squamous Cell Cancer of the Head & Neck
  • YERBA SALON 1-2: CWRU 1301: Phase I Study of the EGFR Tyrosine Kinase Inhibitor Erlotinib (Tarceva) in Combination with Docetaxel & Radiation
  • YERBA SALON 1-2: Detection of Promoter Hypermethylation of Multiple Genes in tumor and Serum Samples of Patients with HNSCC
  • YERBA SALON 1-2: The Effect of Over Expression of the Intrinsic Hypoxia Markers HIF1a, CA-IX and GLUT-1 on local Recurrence in T1/T2 Glottic Laryngeal Carcinoma Treated with Radiation Therapy
  • YERBA SALON 1-2: Noninvasive Detection of HPV & Associated Genetic Alteration in Squamous Head & Neck Cancer
  • YERBA SALON 1-2: Quantitative Methylation Analyses of Resection Margins Predict Local Recurrences and Disease specific survivals in Head & Neck Squamous Cell Carcinomas
  • YERBA SALON 1-2: Engineering an Artificial Salivary Gland
  • YERBA SALON 3-4: Functional Imaging Evaluation of Response to Therapy
  • YERBA SALON 3-4: ASHNR Panel: Post-treatment Imaging and Complications
  • YERBA SALON 3-4: Novel Targeted Therapeutic Approaches to Squamous Cell Carcinoma of the Head & Neck
  • YERBA SALON 3-4: Pitfalls in PET/CT/MR of the Post-treatment Head & Neck Cancer Patients
  • YERBA SALON 3-4: Radiation Therapy Planning Novel PET Tracers
  • YERBA SALON 3-4: HPV16 and Oropharyngeal Cancer
  • YERBA SALON 3-4: FDG-PET for Head & Neck Cancer: Initial Starting
  • YERBA SALON 5-6: Genetic Classification of Head & Neck Cancer
  • YERBA SALON 5-6: Proteomic Profiling to Predict Chemotherapy Response in HNSCC
  • YERBA SALON 5-6: Head & Neck Cancer Virology
  • YERBA SALON 5-6: Oral HPV Infection
  • YERBA SALON 5-6: EBV and NPC: Diagnostic and Therapeutic Opportunities
  • YERBA SALON 5-6: Utilization of Protein Arrays for Head & Neck Cancer Analyses
  • YERBA SALON 5-6: HPV as a Risk Factor for Head & Neck Cancer
  • YERBA SALON 5-6: Expression Array Analyses to Predict HNSCC Behavior
  • YERBA SALON 5-6: Genomics/Proteomics in Head & Neck Cancer
  • YERBA SALON 10-11: Sentinel Node Biopsy in Oral/Oropharyngeal Squamous Cell Cancer
  • YERBA SALON 10-11: Sentinel Lymph Node Biopsy for Squamous Cell Carcinoma of the Oral Cavity
  • YERBA SALON 10-11: TH1/TH2 CD4+ T Helper Responses Against Wild-type Sequence P53 Peptides in HLA-DP5 Patients with Head & Neck Cancer
  • YERBA SALON 10-11: The Important of Immunohistochemistry in Sentinel Lymph node Analysis in Head & Neck Cancer
  • YERBA SALON 10-11: Epigenetic Effect of Gossypol in In-vitro Suppression of Head & Neck Squamous Cell Carcinoma
  • YERBA SALON 10-11: Promoter Hypermethylation and Hypomethylation in Oral Squamous Cell Carcinoma
  • YERBA SALON 10-11: Ligands on Head & Neck Squamous Cell Carcinoma Mediate Low Shear-resistant Binding to Lymphocytes via L-selectin
  • YERBA SALON 10-11: Interleukin 8 is Regulated by Transcription Factor ATF2 in HNSCC
  • YERBA SALON 10-11: Selective Versus Comprehensive Neck Dissection after Chemoradiation Therapy for Advanced Head & Neck Squamous Cell Carcinoma
  • YERBA SALON 10-11: Relative Efficacy of Histopathology, IHC and RT-PCR to detect Occult Metastasis in Sentinel Lymph Nodes
  • YERBA SALON 10-11: How Many Nodes are needed to Stage a Neck?
  • YERBA SALON 10-11: Radiation and Cisplatin require an Immune Mechanism for Curing HPV + Cancer
  • YERBA SALON 10-11: Planned Neck Dissection (PND) after Chemoradiotherapy in Locally Advanced Head & Neck Cancer
  • YERBA SALON 10-11: Incidence of Regional Recurrences after Radiotherapy for Head & Neck Squamous Cell Carcinoma (HNSSC)
  • YERBA SALON 10-11: Global Proteomic Analysis of HNSCC Identifies Prognostic Peptides
  • YERBA SALON 10-11: Proinflammatory Mediators Upregulate Snail in HNSCC
  • YERBA SALON 10-11: Defining an Epigenetic Continuum to Malignancy in Laryngeal Papillomatosis
  • YERBA SALON 10-11: Triggering of TLR4 or TLR9 on Human Head & Neck Squamous Cell Carcinomas (HNSCC) Induces Distinct Biological Effects
  • YERBA SALON 12-13: Minor Salivary Gland Carcinoma of Oropharynx and Oral Cavity
  • YERBA SALON 12-13: 3D Tomosynthesis: Novel “Real-Time” Intraoperative Imaging Technology for Guidance of Skull Base Surgery
  • YERBA SALON 12-13: Does Scar Length Really Matter in thyroid Surgery: a Prospective Randomized Clinical Trial
  • YERBA SALON 12-13: Efficacy of Recurrent Laryngeal monitoring in an Otolaryngology Academic Training Program
  • YERBA SALON 12-13: Elevated Postoperative PTH Levels in Primary Hyperparathyroidism
  • YERBA SALON 12-13: Usefulness of Intraoperative Methylene Blue Infusion in Parathyroidectomy for Secondary Hyperparathyroidism
  • YERBA SALON 12-13: Preoperative Localization of Parathyroid Adenomas Using SPECT-CT Imaging
  • YERBA SALON 12-13: Paratracheal Neck Dissection: Indications, Technique, Surgical Results
  • YERBA SALON 12-13: Comparison of Trends in Incidence and Mortality from thyroid Cancer in the UK and USA
  • YERBA SALON 12-13: Outpatient Thyroidectomy: Experience in over 200 Patients
  • YERBA SALON 12-13: Ultrasound of Cervical Lymph Nodes
  • YERBA SALON 14: Carotenoids: Friend or Foe in Cancer Chemoprevention
  • YERBA SALON 14: Tube Feeding in Head & Neck Cancer Patients Receiving Radiotherapy and Chemotherapy
  • YERBA SALON 14: Complementary Serum Test of Antibodies to EBV EA+EBNA-1: a Possible Alternative for Primary Screening of NPC
  • YERBA SALON 14: Does Neck Dissection after Chemoradiation therapy for Oropharyngeal Carcinoma Affect Swallowing Function?
  • YERBA SALON 14: Influences and Predictors of Long-term Quality of Life in Head & Neck Cancer Survivors
  • YERBA SALON 14: Merck-Serono: Honoraria for Lectures
  • YERBA SALON 14: Auto-fluorescence screening for Oral Pre-malignant and Malignant Lesions
  • YERBA SALON 14: Is EGG Based Videostroboscopic Assessment of To Speech Really Useful?
  • YERBA SALON 14: Sequential Pattern of Plasma EBVDNA Copies in a Cohort of High Risk Non-NPC Patients
  • YERBA SALON 14: Early Results of a Long-term Screening Program for Nasopharyngeal Carcinoma
  • YERBA SALON 14: Swallowing Function Following Radiotherapy or Chemoradiotherapy for Advanced Stage Head & Neck Cancer
  • YERBA SALON 14: Pharyngoesophageal Strictures in Head & Neck Cancer
  • YERBA SALON 14: A Tale of Two Sites: Correlation of HPV Subtypes in SCCHN Patients and Cervix of Appalachian Women in West Virginia
  • YERBA SALON 14: Parenteral vs. Enteral nutrition after Major Neck Surgeries
  • YERBA SALON 14: Cigarette Smoke Regulates Reactive Oxygen Species Metabolism in the Larynx
  • YERBA SALON 14: Smokescreens and Slights of Hand
  • YERBA SALON 14: Genetic Analysis of Sporadic and Familiar Head & Neck Paraganglioma Tumors
  • YERBA SALON 14: Nutrition & Dietetic Led Gastrostomy Pathway of Care for Insertion & Removal contributes to Outcomes
  • YERBA SALON 14: Long-term Results of Provax ActiValve, Solving the Problem of Frequent Canida-and “underpressure”-related Voice Prosthesis Replacements
  • YERBA SALON 15: Assessment of Quality of Life Following Anterior Skull Base Tumor Resection a Prospective Study
  • YERBA SALON 15: Breaking Robustness: A Model for Head & Neck Cancer Progression
  • YERBA SALON 15: The Effect of Autologous Platelet Adhesives on Dermal Fat Graft Resorption Following Reconstruction of a Superficial Parotidectomy
  • YERBA SALON 15: EIF2c2 is Amplified and Over-expressed in HNSCC
  • YERBA SALON 15: Low Level Expression of MicroRNA’s let7-d and miR-205 are Prognostic Markers of Head & Neck Squamous cell Carcinoma
  • YERBA SALON 15: Gene expression Profiles Associated with Metastasis and Survival in Patients will Oral Tongue SCC
  • YERBA SALON 15: Intra-tumoral Lymphatics Correlates with Regional Metastases in the Tongue Cancer
  • YERBA SALON 15: Surgical Technique of “Facial Dismasking Approach” for Craniofacial Lesion
  • YERBA SALON 15: Nomogram for Disease-specific Survival in HNSCC
  • YERBA SALON 15: Genetic Expression Associated with Oral Cancer Identifies a Group of Patients at High-risk of Poor Survival
  • YERBA SALON 15: Microvascular Free Tissue Transfer for Defects of the Scalp and Lateral Temporal Bone
  • YERBA SALON 15: Endoscopic Dural Resection in the Management of Selected Sino-nasal Malignancies: Surgical Technique and Morbidity
  • YERBA SALON 15: Preclinical Development of a Novel Cancer Cell Homing, PKCε Inhibitory Peptide for Head & Neck Cancer
  • YERBA SALON 15: Parathyroid Carcinoma
  • YERBA SALON 15: CT-MIBI Fusion Localization in Directed Parathyroidectomy
  • YERBA SALON 15: Assessing the Impact of Variations in Baseline Parathyroid Hormone Levels on surgical Treatment of Primary Hyperparathyroidism
  • YERBA SALON 15: 634 Directed Parathyroidectomies: Lessons Learned
  • YERBA SALON 15: Ubc9 Expression by HNSCC: Correlation with Clinical Parameters and Proliferation
  • YERBA SALON 15: Navigated Control: Surgical Assistance for Skull Base Surgery
  • YERBA SALON 15: Results of Proton Beam Radiation therapy for Locally Advanced Squamous Cell Carcinoma (SCC) of the Paranasal Sinus and Nasal Cavity
  • YERBA SALON 15: Clinical Outcomes of Sinonasal Cancer Treated with Endoscopic Endonasal Resection
  • YERBA SALON 15: Treatment of Esthesioneuroblastoma with a Completely Endoscopic Endonasal Cranial Base Resection
  • PACIFIC B: Session – LWP02. Cancer Prevention and Premalignancy
  • PACIFIC C: CT/MR for Assessing Treatment Response
  • PACIFIC C: Avoiding Pitfalls in the Post-Treatment Neck
  • PACIFIC E: “Minimally Invasive” Paranasal Sinus-Cranial Base Surgery
  • PACIFIC F: Non-PET-based Techniques for Functional H+N Imaging
  • PACIFIC F: Imaging for Surveillance
  • PACIFIC F: Imaging for surveillance Part II: Case Examples
  • PACIFIC H: PET/CT in Neck Imaging: Practical Considerations
  • PACIFIC H: PET in Head & Neck
  • PACIFIC J: Ultrasound in Head & Neck Cancer Staging: Case Studies
[/tab][tab title=”Monday“]
  • YERBA SALON 1-3: Mandibular Condyle Reconstruction with Fibular Free Tissue Transfer
  • YERBA SALON 1-3: Versatility of the ALT Flap in Head & Neck Reconstruction
  • YERBA SALON 1-3: Perioperative Airway Management in Patients receiving Oral cavity Free flap Reconstruction: Can Tracheotomy be Safely Avoided?
  • YERBA SALON 1-3: Free Posterior Tibial Flap for Head & Neck Reconstruction after Tumor Resection
  • YERBA SALON 1-3: Mandibular Defect Reconstruction with Composite Free Flaps and the Use of the 2.0 mm Unilock system
  • YERBA SALON 1-3: Designing Chimera Flaps in Multiple Vascular systems
  • YERBA SALON 1-3: Screening of Hypopharyngeal Cancer with the Hooded Videoendoscopy and the Narrow Band Imaging for Esophageal Cancer Patients
  • YERBA SALON 1-3: Stereolithographic Biomodeling in Mandibular Reconstruction: a Prospective Trial
  • YERBA SALON 1-3: Supraclavicular Artery Flap for Oncologic Head & Neck Reconstruction
  • YERBA SALON 4-6: Salvage Surgery for Recurrent H&N Cancer
  • YERBA SALON 4-6: Novel Strategies and Principles of Management of Recurrent Cancer of the Head & Neck
  • YERBA SALON 4-6: Assaulting Therapeutic Barriers: Re-irradiation and Chemotherapy in Recurrent SCCHN
  • YERBA SALON 4-6: Local Regional Recurrent Disease
  • YERBA SALON 10-11: Immunostaining Patterns of CD31 and Podoplanin in Previously Untreated Advanced Oral/Oropharyngeal Cancer
  • YERBA SALON 10-11: A Prospective Study of Surgical Margin Status in Oral Squamous Cell Carcinoma – A Preliminary Report
  • YERBA SALON 10-11: Management of the Clinically No Neck in Oral and Oropharyngeal Carcinoma in Scotland
  • YERBA SALON 10-11: Enhancement of Antitumor Activity Using Cetuximab and novel Epidermal Growth Factor Receptor (EGFR) Peptide-specific T Cells
  • YERBA SALON 10-11: Identification of Stem-like Calls in Head & Neck Cancer Cell Lines
  • YERBA SALON 10-11: The Toll-like Receptor 9 Agonist ODN1826 Inhibits Cachexia and Tumor Growth in Tumor-Bearing Mice
  • YERBA SALON 10-11: Synergistic Effect of Resveratrol with Etoposide and Cisplatin in Merkel Cell Carcinoma Cell Lines
  • YERBA SALON 10-11: Salivary Transcriptomes as Potential Early Detection Biomarkers for Oral Cancer
  • YERBA SALON 10-11: Metastases to Level llb in Oral Cavity Cancer: A Systematic Review and Meta-analysis
  • YERBA SALON 10-11: Vaccination with Ad E6/E7 Prevents HPV Related Cancer in Vivo
  • YERBA SALON 10-11: Analysis of Risk Factors Predictive of Local Tumor Control in Oral Cavity Cancer
  • YERBA SALON 10-11: Factor Contributing Need of Tracheostomy and Strategies to Overcome that in Patients Undergoing Oral and Oropharyngeal Cancer surgery
  • YERBA SALON 10-11: Marginal Mandibulectomy for Buccal Sulcus Cancers: 10 Year Institutional Experience
  • YERBA SALON 10-11: Sequential Therapy for Locally Advanced Larynx and Hypopharynx Cancer
  • YERBA SALON 10-11: FGF2-retageted Adenoviral Gene Therapy for MRN Disruption Induces Cisplatin Chemosensitization for Head & Neck Cancer
  • YERBA SALON 12-13: Autofluorescence Imaging and Molecular Markers combined, Provide a Robust Predictive Strategy in Oral Cavity Malingnancy
  • YERBA SALON 12-13: The Role of Imaging Studies for the Detection of Retropharyngeal Lymph Node Metastasis in Head & Neck Cancer
  • YERBA SALON 12-13: Detection of Pulmonary Tumours in Patients with Head & neck Squamous Cell Carcinoma at the time of Original Presentation
  • YERBA SALON 12-13: Is there any Additional Value of SPECT/CT Over Lymphoscintigraphy for Sentinel node Mapping in Oral/Oropharyngeal SCC?
  • YERBA SALON 12-13: Organ Preservation with Concurrent Chemoradiation for Advanced Laryngeal Cancer: Are We Succeeding?
  • YERBA SALON 12-13: RECISTing the Neck: Interobserver Variability in the Use of RECIST Criteria for Neck Tumors
  • YERBA SALON 12-13: PET-CT in the Management of Head & Neck Malignancies
  • YERBA SALON 14-15: An Evaluation of Trends in the Quality of Research in the Subspecialty of Head & Neck Oncology
  • YERBA SALON 14-15: Socioeconomic Status as a Predictor of Survival in Head & Neck Cancer Patients
  • YERBA SALON 14-15: How Representative are Published Studies in Patients with Head & Neck Cancer of the Total Population of Patients?
  • YERBA SALON 14-15: Are We Overestimating the Risk of Second Malignancies in Patients with Head & Neck Cancer?
  • YERBA SALON 14-15: Second Primary Tumours in Laryngeal SCCs are not Associated with Poorer Overall Outcome and Survival
  • YERBA SALON 14-15: Microvascular changes in Oral Mucositis
  • YERBA SALON 14-15: Prospective Multicenter phase III Randomized Study Comparing Oral Pilocarpine vs. Submandibular Salivary gland Transfer Protocol for the Management of XRT Induced Xerostomia
  • YERBA SALON 14-15: Telomerase Activity in Peripheral Whole Blood of Head & Neck Squamous Cell Carcinoma Patients Before and after Surgery
  • YERBA SALON 14-15: Anon-invasive Diagnostic Technique Using Time-resolved Laser-induced Fluorescence Spectroscopy in the Hamster model
  • YERBA SALON 14-15: A 3-D Interactive Pathology Visualization System
  • YERBA SALON 14-15: Oral Cancer Trends Over Three Decades from 1984-2004 in the West Midlands, UK
  • YERBA SALON 14-15: Bioengineered Human Salivary Tissue Constructs for the Treatment of Radiation Induced Xerostomia
  • YERBA SALON 14-15: Trans Oral Robotic Surgery (TORS)
  • PACIFIC A: Early Laryngeal Cancer
  • PACIFIC B: T3N3 Tumor of the Hypopharynx: No Significant Comorbidities
  • PACIFIC B: Induction Chemotherapy and Concomitant Chemoradiotherapy for Locoregionally Advanced Head & Neck Cancer
  • PACIFIC C: Role of Surgery in the Palliative Treatment of Head & Neck Carcinoma
  • PACIFIC E: Practice Guidelines: Cost Control in Head & Neck Cancer
  • PACIFIC E: Organ Preservation in Brazil. Can We Afford It?
  • PACIFIC F: Symptom control for Non-Surgical Treatments
  • PACIFIC H: Progress in Medical Treatment of Incurable Salivary Gland and Thyroid Cancers
  • PACIFIC H: Novel Agents in Thyroid Cancer
  • PACIFIC I: Angiogenesis Inhibition in HNSCC
  • PACIFIC J: Target Therapy. Kinase Inhibition.
[/tab][tab title=”Tuesday“]
  • YERBA SALON 1-3: Biomarkers in Oral Dysplasia: A systematic Review
  • YERBA SALON 1-3: Unilateral Thyroid Lobectomy for Differentiated thyroid Carcinoma
  • YERBA SALON 1-3: Marginal Mandibular Nerve Injury in Neck Dissection and its Impact on Patient Perception of Appearance
  • YERBA SALON 1-3: Comparing Prognostic Outcomes of Tall Cell Variant to Normal Variant Papillary Thyroid Carcinoma: a Meta-analysis
  • YERBA SALON 1-3: Early Experience Using Time – and Swept Source Frequency domain Optical coherence Tomography in Head & Neck Oncology
  • YERBA SALON 1-3: The Influence of Passive vs Suction Drainage on Complications Following Neck Dissection
  • YERBA SALON 1-3: Substernal Goiters and Sternotomy
  • YERBA SALON 1-3: Outcomes of Untreated Papillary Thyroid Cancer
  • YERBA SALON 1-3: Molecular Imaging of Sentinel Lymph Mode Metastases Using Oncolytic Herpes Simplex Virus-mediates Transgene Expression
  • YERBA SALON 1-3: Surgical Management of Well Differentiated Thyroid Carcinoma
  • YERBA SALON 1-3: Colour Flow Doppler and the Anterolateral Thigh Flap: Clinical Utility
  • YERBA SALON 1-3: Risk-adjusted Use of FDG-PET/CT in Radiation Response Assessment for HNSCC
  • YERBA SALON 1-3: Shoulder Morbidity Following Pectoralis Major Flap Reconstruction
  • YERBA SALON 1-3: Chemo-selection as a Strategy for Organ Preservation
  • YERBA SALON 1-3: Geldanamycin Treatment Radiosensitize Head & Neck Carcinoma Cells by Promoting EGFR Degradation
  • YERBA SALON 1-3: ICC 2302: Phase II Study of Combretastatin A4 Phosphate (CA4P, Fosbretabulin) on Advanced Anaplastic Thyroid Carcinoma
  • YERBA SALON 1-3: Complications of total Thyroidectomy in Benign vs Maligant Disease
  • YERBA SALON 1-3: Comparison of Post-operative Complications after Thyroidectomy with and without Central Compartment Dissection
  • YERBA SALON 1-3: Papillary Thyroid Cancer in Children: Management and Patterns of Failure
  • YERBA SALON 4-6: Neuroradiology of Nasopharyngeal Cancer Diagnosis and Patterns of Spread
  • YERBA SALON 4-6: Chemo/IMRT. IMRT-Debates
  • YERBA SALON 4-6: The Radiation Oncologists Cannot Reproducibly Choose What to Treat
  • YERBA SALON 4-6: IMRT, Especially when Combined with Chemo, is too Toxic and Dangerous
  • YERBA SALON 4-6: Conclusions
  • YERBA SALON 4-6: Chemo/IMRT is either too Toxic or too Dangerous… The Cons…
  • YERBA SALON 4-6: Nasopharyngeal Cancer
  • YERBA SALON 4-6: IMRT in the Treatment of Nasopharyngeal Carcinoma (NPC)
  • YERBA SALON 4-6: Nasopharyngeal Cancer
  • YERBA SALON 4-6: Nasopharyngeal Carcinoma: Recurrent Metastatic and biologic Targeted therapy
  • YERBA SALON 10-11: Expression of CD24, EGFR, and MDM2 Predict Disease Specific Survival in Patients with Advanced Laryngeal Cancer
  • YERBA SALON 10-11: Response to Induction Chemotherapy and Chemoradiation is Predicted by Low Expression of BAK and NFkB in Patients with Advanced Laryngeal Cancer
  • YERBA SALON 10-11: Shoulder Morbidity after Surgical and Non-surgical Treatment of the Neck
  • YERBA SALON 10-11: Expression of Hedgehog Signaling Molecules in Merkel Cell Carcinoma
  • YERBA SALON 10-11: The Clinical Significance of Loss of Heterozygosity in Head & Neck Squamous Cell Carsinoma
  • YERBA SALON 10-11: Molecular Staging of Surgically Treated Head & Neck Cancer Patients
  • YERBA SALON 10-11: Improved Outcome with Neck Dissection Following Chemoradiation for N3 Disease
  • YERBA SALON 10-11: Positron Emission Tomography in the Management of Head & Neck Cancer of Unknown Primary
  • YERBA SALON 10-11: Quality of Life after Neck Dissection
  • YERBA SALON 10-11: Diffusion-weighted MRI for Nodal Staging of Locally Advanced Head & Neck Squamous Cell Carcinoma: Impact on Radiotherapy Planning
  • YERBA SALON 10-11: DCE-MRI Perfusion Imaging of HNSCC Nodal Metastasis
  • YERBA SALON 10-11: The Prognostic Significance of Tumour HIF-1a Expression for Outcome Following Radiotherapy in Oropharyngeal Cancer
  • YERBA SALON 10-11: Initial Staging of the Neck in HNSCC: is PET/CT the best?
  • YERBA SALON 10-11: FcγIIIA Polymorphisms and Cetuximab Induced Cytotoxicity in SCCHN
  • YERBA SALON 10-11: The role of PGP9.5 as a Tumor Suppressor Gene in Head & Neck Cancer
  • YERBA SALON 10-11: Ultrasound Guided Aspiration Cytology for the Assessment of the clinical NO Neck; Factors Influencing its Accuracy
  • YERBA SALON 12-13: Low Molecular Weight Heparin Thromboprophylaxis and Bleeding risk in Head & Neck Cancer Microvascular Reconstruction
  • YERBA SALON 12-13: Mandibular Reconstruction with Autologus Freeze-treated Bone after Malignant Tumor Resection
  • YERBA SALON 12-13: Free Jejunum Versus Tubed Flaps for Total Laryngopharyngectomy Defects: Patterns of Use and Outcomes
  • YERBA SALON 12-13: A New Option in Maxillary Reconstruction
  • YERBA SALON 12-13: Microvascular Reconstruction in the Setting of Prior Intra-arterial Chemotherapy with Concomitant Radiation
  • YERBA SALON 12-13: Reconstruction of Maxillary Defects-options and Outcome
  • YERBA SALON 12-13: Bone Impacted Fibula (BIF)
  • YERBA SALON 12-13: Radial Forearm Versus Anterolateral Thigh Free Flaps for Laryngopharyngectomy Defects
  • YERBA SALON 12-13: A Practical Approach to Maxillary Reconstruction Based Upon the Patient’s Desire for Dental Rehabilitation
  • YERBA SALON 12-13: Combinatorial therapy for Healing Cranial Defects Compromised by Preoperative Radiation
  • YERBA SALON 12-13: A Prospective Analysis of Factors Predicting Morbidity in Microvascular Free Flap Reconstruction of the Head & Neck
  • YERBA SALON 12-13: Pectoralis Myofascial Flap During Salvage Laryngectomy Prevents Pharyngocutaneous Fistula
  • YERBA SALON 12-13: The Use of Radial Forearm Free Flap for total Lower Lip Reconstruction
  • YERBA SALON 12-13: The Role of Salvage Surgery in Recurrent Oropharyngeal Squamous Cell Carcinoma
  • YERBA SALON 12-13: Efficacy of Low Molecular Weight Heparin in Preventing Free Flap Failure: A Rat Model
  • YERBA SALON 12-13: The Use of Stress-Shielding Reconstruction Plates in Free Fibula Mandible Reconstruction May be Associated with Increase Rates of Bone Resorption
  • YERBA SALON 14-15: Random Positional Variation Amongst the Skull, Mandible and cervical Spine in Daily Setup for Head & Neck Radiotherapy
  • YERBA SALON 14-15: Laser Vestibulectomy for Supraglottic Carsinomas
  • YERBA SALON 14-15: Laser Surgery of Early Glottic Cancer
  • YERBA SALON 14-15: Predictors of outcome for Advanced Stage Supraglottic Laryngeal cancer
  • YERBA SALON 14-15: Two-Year Longitudinal Study of Swallowing After Chemotherapy-IMRT for Head & Neck Cancer
  • YERBA SALON 14-15: Complications and Findings in Panendoscopy of Chemoradiated Patients
  • YERBA SALON 14-15: Endoscopic C02 Laser Supraglottic Laryngectomy Multicenter Analysis of 144 cases
  • YERBA SALON 14-15: Treatment of Pharyngeal carcinomas by Laser Endoscopic Microsurgery
  • YERBA SALON 14-15: Clinical Impact of Introducing Supracricoid Laryngectomy with CHEP
  • YERBA SALON 14-15: Do Team Member Managing Head & Neck Cancer Have the same or different Views when Predicting Quality of Life?
  • YERBA SALON 14-15: Functional Outcomes and Quality of Life
  • YERBA SALON 14-15: Clinical Predictors of Survival with Functional Larynx Preservation after Multiagent Concurrent Chemotherapy and Radiation
  • YERBA SALON 14-15: Validation of the EORTC Quality of life Instruments in Laryngeal Cancer Patients after Surgery
  • YERBA SALON 14-15: Interstitial PDT in Recurrent Head & Neck Carcinoma
  • YERBA SALON 14-15: Phonosurgical Treatment of Early Glottal Cancer: Innovations Through the Past 15 Years
  • PACIFIC B: Hypoxia Research and clinical Practice
  • PACIFIC B: Secreted & Tissue Markers for Hypoxia & Prognosis in Head & Neck Cancer
  • PACIFIC E: Proton Beam Radiation for Head & Neck Cancer
  • PACIFIC H: Current Strategies for Management of XRT Induced Xerostomia
  • PACIFIC J: Orbital and Periorbital Hemangiomas and Vascular Malformations
[/tab][tab title=”Wednesday“]
  • YERBA SALON 1-3: Prevalence of K-RAS Codon 12 Mutations in Locally Advanced Head & Neck Squamous Cell Carcinoma and Impact on clinical Outcomes
  • YERBA SALON 1-3: RT-PCR for Cytokeratin 20 for Molecular Diagnosis of Lymphatic Metastases in Patients with Head & Neck Cancer
  • YERBA SALON 1-3: Heparanase Induces VEGF-C Levels and Facilitates Tumor Lymphangiogenesis
  • YERBA SALON 1-3: Immunology and Stem Cells – the Dysfunctional Tumor Microenviroment as a Barrier to Successful Therapy
  • YERBA SALON 1-3: SCCHN Can Induce T Cell Senescence as a Novel form of Immune Escape
  • YERBA SALON 1-3: PGE² Production is Enhanced in UV Exposed Keratinocytes: Evidence for the Role of 15-Hydroxyprostaglandin Dehydrogenase
  • YERBA SALON 1-3: Tetrathiomolybdate inhibits Head & Neck cancer Metastasis by Decreasing Tumor Cell Invasion & Promoting Tumor Cell Anoikis
  • YERBA SALON 1-3: Oncolytic Herpes Simplex Virus OncoVEX(GALV/CD) Prodrug Activation Enhances Viral Cytotoxicity in Head & Neck Squamous Cell Carcinoma
  • YERBA SALON 1-3: Cancer Stem Cells in Head & Neck Cancer
  • YERBA SALON 1-3: Lymphocyte Homing Receptor/Tumor Ligand Interactions: a Putative Mechanism for Promoting Immune Tolerance
  • YERBA SALON 1-3: Prediction of Local Recurrence after Radiotherapy for Larynx Carcinoma Using Tissue array Immunohistochemistry
  • YERBA SALON 1-3: Inflammatory and Pattern Recognition Receptors Expressed by Cancer Cells
  • YERBA SALON 1-3: EGFRvIII Induces HNSCC Tumor Cell Migration and Invasion via Activation of STAT3
  • YERBA SALON 4-6: Surgery for Preservation of Swallowing
  • YERBA SALON 4-6: The Role of p53 Mutations in Mouse Models for Oral Cancer
  • YERBA SALON 4-6: Measuring and Quantifying Dysphasia
  • YERBA SALON 4-6: Orthotopic Models of Head & Neck Cancer Including Oral SCCA, Thyroid CA, & Salivary CA
  • YERBA SALON 4-6: Swallowing
  • YERBA SALON 4-6: Swallowing and Quality of Life
  • YERBA SALON 4-6: Panel: Mouse Model for Head & Neck Cancer
  • YERBA SALON 4-6: Dissecting Genetic Alterations and Microenvironment Contributing to HNSCC using Mouse Tumors as model System
  • YERBA SALON 10-11: Gene Expression and Promoter Polymorphisms of DNMT3B in NPCs in Taiwan: A Case-Control Study
  • YERBA SALON 10-11: Early Oral Feeding after Salvage Laryngectomy
  • YERBA SALON 10-11: The Role of Induction Chemotherapy for the Management of Sinonasal Undifferentiated Carcinoma
  • YERBA SALON 10-11: Oropharyngeal SCC. Is there a Role for Primary Surgery?
  • YERBA SALON 10-11: Wide Vertical Hemipharyngolaryngectomy for Laryngopharyngeal Cancer: Revised Surgical Technique & Classification
  • YERBA SALON 10-11: Conservative Management of Iatrogenic Esophageal Perforation in Head & Neck Cancer Patients with Esophageal Stricture
  • YERBA SALON 10-11: Supracricoid Partial Laryngestomy after Radiation Failure
  • YERBA SALON 10-11: Endoscopic Treatment for T1-T3 Supraglottic Cancer: a Multi-institutional Series of 127 Patients
  • YERBA SALON 10-11: Stereotactic Radiosurgery for Head & Neck and Skull Base Cancer
  • YERBA SALON 10-11: PET/CT in Previously Treated Skull Base Malignancies
  • YERBA SALON 10-11: Nasopharyngectomy for Recurrent Nasopharyngeal Carcinoma
  • YERBA SALON 10-11: Speech and Swallowing Following Microsurgical Reconstruction of Soft Palate
  • YERBA SALON 10-11: Salvage Laryngectomy Following Organ Preservation Protocols
  • YERBA SALON 10-11: Fascia-only Free Radial Forearm Flap for Resurfacing the Nasopharynx Following Nasopharyngectomy
  • YERBA SALON 10-11: Endoscopic Transpterygoid Nasopharyngectomy for the Treatment of Nasopharyngeal Carcinoma
  • YERBA SALON 10-11: Changing Treatment Paradigms in the Management of Squamous Cell Carcinoma of the Supraglottic Larynx
  • YERBA SALON 12-13: Squamous Cell carcinoma of Oral Tongue (SCCT) in Young Adults
  • YERBA SALON 12-13: Swallowing Function after Intensity-Modulated and Concomitant Boost Radiation Therapy for Oropharyngeal Carcinoma
  • YERBA SALON 12-13: Assessment of Mouth Self Examination for Early Detection of Oral Cancer in a High-risk Population
  • YERBA SALON 12-13: Prediction of Treatment Complications in Patients with Oropharyngeal Cancer
  • YERBA SALON 12-13: Treatment and Follow-up of Oral Dysplasia
  • YERBA SALON 12-13: Radiotherapy as Single-modality Treatment for Head & Neck Paragangliomas
  • YERBA SALON 12-13: Functional Organ Preservation in T4 Laryngeal/Hypopharyngeal Cancer Treatment with Chemoradiation
  • YERBA SALON 12-13: The Pattern of Failure after Re-irradiation of Recurrent Head & Neck Cancer: Sqamous Cell Cancer (HNSCC)
  • YERBA SALON 12-13: Squamous Cell Carcinoma Regional Metastases Treated with Radiation Therapy: Correlation Between CT and Histology
  • YERBA SALON 12-13: Encouraging Presentation of Oral Cancer in a High Risk Group
  • YERBA SALON 12-13: Utilizing 5-Aminolevulinic Acid and Pulsed Dye Laser for Photodynamic therapy (PDT) of Oral Leukoplakia
  • YERBA SALON 12-13: Lack of Association Between HPV Infection and Oral Tongue Carcinoma in Young and Older Adults
  • YERBA SALON 12-13: A Population-based Analysis of the Association of Oral/Pharyngeal Carcinomas with HPV-Related Anogenital Carcinomas in Men
  • YERBA SALON 12-13: Xerostomia in Patients with Head & Neck Tumors Treated by IMRT: Importance of Absolute Spared Parotid Volume
  • YERBA SALON 12-13: Radical Radiation for Unknown Primary Squamous Cell Cancer Yields high Control but has Major Toxicity Suggesting Need for New Treatment Parading
  • YERBA SALON 12-13: A Food-based Approach to Oral Cancer Chemoprevention
  • YERBA SALON 12-13: Dosimetric Uncertainties in Matched IMRT and Conventional Fields for Head & Neck Cancer Radiotherapy
  • YERBA SALON 14-15: “Dual disruption” Therapy for Head & Neck Cancer: Targeting DNA Repair Pathways to Induce Cancer Cell Death
  • YERBA SALON 14-15: Cisplatin and JSI-124 Induce Synergistic Cell Death in a Cisplatin Resistant Cell Line
  • YERBA SALON 14-15: Peri-tumoral Injections of Purified Tumstatin Delay Tumor Growth & Lymphatic Metastasis in an Orthotopic Oral SCC Model
  • YERBA SALON 14-15: Single-walled Carbon Nanotubes Associated with Paclitaxel Inhibit the Growth of Head & Neck Squamous Cell Tumors
  • YERBA SALON 14-15: Salvage Surgery for Recurrent Nasopharyngeal Carcinoma Using a Partial Maxillectomy Approach
  • YERBA SALON 14-15: Metronomic Administration of a Small Molecule Inhibitor of Bcl-2 Combined with Cisplatin in Xenografted Head & Neck Cancer
  • YERBA SALON 14-15: Sensitization of Head & Neck Cancer Cells to Cisplatin is Potentiated by Genistein
  • YERBA SALON 14-15: Preclinical Evaluation of Sunitinib in Squamous Cell Carcinoma of the Head & Neck
  • YERBA SALON 14-15: Hyaluronan and CD44 Interact with RHO-kinase and PI 3-kinase to Promote Gowth, Migration, Invasion, and Cisplatin Resistance in HNSCC
  • YERBA SALON 14-15: Assessment of EGFR Inhibition by Erlotinib in Tumors as Compared with normal Mucosa in Patients with Oral Cavity Squamous Cell Carcinoma
[/tab][/tabs]

Share:

  • Facebook
  • Twitter
  • LinkedIn

News and Announcements

  • Journal Club May 2025 hosted by the Cutaneous Cancer Section for Skin Cancer Awareness Month May 23, 2025
  • AHNS YMCP Episode 11 – Melina Windon, MD, Janice Farlow, MD, Eric Gantwerker, MD May 8, 2025
  • Artificial Intelligence in Management of H&N Cancer: New Horizons Presented April 28, 2025
  • A conversation with Dr. Uppaluri: Neoadjuvant Therapy for Advanced H&N Mucosal April 25, 2025
  • The End of April Head and Neck Cancer Awareness Month Approaches! April 23, 2025

AHNS Meetings and Events

AHNS 2025 Annual Meeting
Held during the Combined Otolaryngology Spring Meetings (COSM)

May 14-18, 2025
Hyatt Regency New Orleans
New Orleans, Louisiana

learn more...

Contact Us

AHNS, 11300 W. Olympic Blvd, Suite 600
Los Angeles, CA 90064
ph: (310) 437-0559 / fx: (310) 437-0585
[email protected]

Welcome to the AHNS Virtual Repository of Scientific Research

Sections

  • Virtual Repository of Scientific Resources
  • Cell Lines Browse and Search
  • Omics Browse and Search
  • Patient Derived Xenografts Browse and Search
  • Plasmids Browse and Search
  • Pre-Clinical Models Browse and Search
  • Transferable Expertise Browse and Search
  • Transgenic Mice Browse and Search

© 2002–2025 American Head and Neck Society · Privacy and Return Policy
· Managed by BSC Management, Inc